Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-003241
Filing Date
2025-02-05
Accepted
2025-02-05 19:47:19
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5981
  Complete submission text file 0001140361-25-003241.txt   7520
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 HOYT ST APT 15E BROOKLYN NY 11201
Business Address
Pratumsuwan Piratip (Reporting) CIK: 0002055179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 25595005